These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37055887)

  • 1. Anticancer Compounds from Cyanobacteria and their Implications in Apoptosis.
    Gupta A; Singh PR; Singh AP; Kumari N; Jaiswal J; Sahu N; Mishra S; Pathak J; Sinha RP
    Curr Protein Pept Sci; 2023; 24(10):805-819. PubMed ID: 37055887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis.
    Costa M; Costa-Rodrigues J; Fernandes MH; Barros P; Vasconcelos V; Martins R
    Mar Drugs; 2012 Oct; 10(10):2181-2207. PubMed ID: 23170077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyanobacteria as Natural Therapeutics and Pharmaceutical Potential: Role in Antitumor Activity and as Nanovectors.
    Qamar H; Hussain K; Soni A; Khan A; Hussain T; Chénais B
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33466486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyanobacteria derived compounds: Emerging drugs for cancer management.
    Shahid A; Khurshid M; Aslam B; Muzammil S; Mehwish HM; Rajoka MSR; Hayat HF; Sarfraz MH; Razzaq MK; Nisar MA; Waseem M
    J Basic Microbiol; 2022 Sep; 62(9):1125-1142. PubMed ID: 34747529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pramanicin analog induces apoptosis in human colon cancer cells: critical roles for Bcl-2, Bim, and p38 MAPK signaling.
    Bodur C; Kutuk O; Karsli-Uzunbas G; Isimjan TT; Harrison P; Basaga H
    PLoS One; 2013; 8(2):e56369. PubMed ID: 23441183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells.
    Ballestrero A; Nencioni A; Boy D; Rocco I; Garuti A; Mela GS; Van Parijs L; Brossart P; Wesselborg S; Patrone F
    Clin Cancer Res; 2004 Feb; 10(4):1463-70. PubMed ID: 14977850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivo.
    Bai L; Chen J; McEachern D; Liu L; Zhou H; Aguilar A; Wang S
    PLoS One; 2014; 9(6):e99404. PubMed ID: 24901320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
    Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
    Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737.
    Mathieu AL; Sperandio O; Pottiez V; Balzarin S; Herlédan A; Elkaïm JO; Fogeron ML; Piveteau C; Dassonneville S; Deprez B; Villoutreix BO; Bonnefoy N; Leroux F
    J Biomol Screen; 2014 Aug; 19(7):1035-46. PubMed ID: 24809353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer and Apoptosis.
    Chaudhry GE; Akim AM; Sung YY; Muhammad TST
    Methods Mol Biol; 2022; 2543():191-210. PubMed ID: 36087269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inhibitor of Bcl-2 family proteins induces regression of solid tumours.
    Oltersdorf T; Elmore SW; Shoemaker AR; Armstrong RC; Augeri DJ; Belli BA; Bruncko M; Deckwerth TL; Dinges J; Hajduk PJ; Joseph MK; Kitada S; Korsmeyer SJ; Kunzer AR; Letai A; Li C; Mitten MJ; Nettesheim DG; Ng S; Nimmer PM; O'Connor JM; Oleksijew A; Petros AM; Reed JC; Shen W; Tahir SK; Thompson CB; Tomaselli KJ; Wang B; Wendt MD; Zhang H; Fesik SW; Rosenberg SH
    Nature; 2005 Jun; 435(7042):677-81. PubMed ID: 15902208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis.
    Song JH; Kandasamy K; Kraft AS
    J Biol Chem; 2008 Sep; 283(36):25003-13. PubMed ID: 18599488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.
    Doshi JM; Tian D; Xing C
    J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phosphatidylinositol 3-kinase/AKT signaling by NVP-BKM120 promotes ABT-737-induced toxicity in a caspase-dependent manner through mitochondrial dysfunction and DNA damage response in established and primary cultured glioblastoma cells.
    Jane EP; Premkumar DR; Morales A; Foster KA; Pollack IF
    J Pharmacol Exp Ther; 2014 Jul; 350(1):22-35. PubMed ID: 24741074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy.
    Tomek M; Akiyama T; Dass CR
    J Pharm Pharmacol; 2012 Dec; 64(12):1695-702. PubMed ID: 23146031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of 3-phenyl-N-(2-(3-phenylureido)ethyl)-thiophene-2-sulfonamide compounds as inhibitors of antiapoptotic Bcl-2 family proteins.
    Yang C; Chen S; Zhou M; Li Y; Li Y; Zhang Z; Liu Z; Ba Q; Li J; Wang H; Yan X; Ma D; Wang R
    ChemMedChem; 2014 Jul; 9(7):1436-52. PubMed ID: 24782462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
    Richardson A; Kaye SB
    Curr Mol Pharmacol; 2008 Nov; 1(3):244-54. PubMed ID: 20021437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy.
    Alam M; Ali S; Mohammad T; Hasan GM; Yadav DK; Hassan MI
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel peptide isolated from garlic shows anticancer effect against leukemic cell lines via interaction with Bcl-2 family proteins.
    Rasaratnam K; Nantasenamat C; Phaonakrop N; Roytrakul S; Tanyong D
    Chem Biol Drug Des; 2021 May; 97(5):1017-1028. PubMed ID: 33595876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrakurkurone, a sesquiterpenoid from wild edible mushroom, targets liver cancer cells by modulating Bcl-2 family proteins.
    Dasgupta A; Dey D; Ghosh D; Lai TK; Bhuvanesh N; Dolui S; Velayutham R; Acharya K
    IUBMB Life; 2019 Jul; 71(7):992-1002. PubMed ID: 30977280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.